| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +50.00% | +0.77% | +0.54% | +0.23% | -0.70% | — |
| 14d | 4 | +50.00% | +3.29% | +2.01% | +1.29% | -2.97% | — |
| 30d | 4 | +75.00% | +19.54% | +2.70% | +16.83% | +20.55% | — |
| 60d | 4 | +75.00% | +41.44% | +3.54% | +37.90% | +6.73% | — |
| 90d | 4 | +50.00% | +12.22% | +6.67% | +5.55% | -9.28% | — |
| 180d | 4 | +50.00% | -14.86% | +10.83% | -25.69% | -15.13% | — |
| 1y | 4(1 pending) | +33.33% | +67.56% | +26.63% | +40.93% | -101.00% | — |
| 2y | 4(2 pending) | +0.00% | -50.22% | +46.72% | -96.94% | -96.94% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 24,372 | — | — | 24,372 | Jun 4, 2026 | Jun 8, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE | 3,800 | $13.51 | $51.3K | 66,900 | May 21, 2026 | May 26, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE | 8,100 | $12.45 | $100.8K | 63,100 | Dec 23, 2025 | Dec 23, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Jun 5, 2025 | Jun 9, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE | 50,000 | $2.13 | $106.6K | 55,000 | Sep 5, 2024 | Sep 9, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Jun 6, 2024 | Jun 7, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE | 4,000 | $14.97 | $59.9K | 5,000 | Dec 15, 2023 | Dec 19, 2023 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 3,908 | — | — | 3,908 | Jun 8, 2023 | Jun 12, 2023 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 27,403 | — | — | 27,403 | Mar 16, 2023 | Mar 20, 2023 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASE | 1,000 | $31.99 | $32.0K | 1,000 | Mar 16, 2023 | Mar 20, 2023 ↗ | View → |